U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07918573) titled 'Telacebec in Adults With Multibacillary Leprosy (TEBULA Leprosy Trial)' on Sept. 21.
Brief Summary: The goal of this clinical trail is to evaluate whether short-course telacebec-based regimens can induce rapid and measurable reductions in M. leprae viability, potentially establishing the foundation for future shorter, safer, and simplified therapeutic strategies for MB leprosy.
Participants will be randomised into one of the four study arms (A, B, C and D). The arm A is non interventional. For arms B, C, and D, the three-month study drug treatment will be followed by 9 months of MDT, bringing the total treatment time to 12 months. T...